Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
HENNESSY DANIEL J CREVF Carbon Revolution Public Ltd Co 13G 7.1% 3y
Artal Participations S.a r.l KRRO Korro Bio, Inc. 13G 5.2% 3y
Atlas Venture Fund XI, L.P. KRRO Korro Bio, Inc. 13D 11.8% 3y
GLENVIEW CAPITAL MANAGEMENT, LLC DXC DXC Technology Co 13G 5.7% 3y
Ernest C. Garcia II CVNA Carvana Co. 13D/A 43.2% 3y
Deerfield Management Company, L.P. PRLD Prelude Therapeutics Inc 13G 7.68% 3y
Logiq, Inc. CAUD Collective Audience, Inc.. Common Stock 13D 45.6% 3y
EVENTIDE ASSET MANAGEMENT, LLC YARW Yarrow Bioscience, Inc. 13G 9.99% 3y
Stier Jennifer PPLI People Inc 13G 5.2% 3y
PAULSON & CO. INC. MDGL Madrigal Pharmaceuticals, Inc. 13G 5.1% 3y
Michael P. Ibe DEA Easterly Government Properties, Inc. 13D 6.4% 3y
Lynx1 Capital Management LP CCCC C4 Therapeutics, Inc. 13G 6.3% 3y
Cormorant Asset Management, LP YARW Yarrow Bioscience, Inc. 13G 9.99% 3y
VANGUARD GROUP INC NATL NCR Atleos Corp 13G 10.15% 3y
Capital Research Global Investors HAS Hasbro, Inc. 13G 10.1% 3y
BIOTECHNOLOGY VALUE FUND L P ENGN enGene Therapeutics Inc. 13G 13.2% 3y
Invesco Ltd. DVVY Invesco Actively Managed Exchange-Traded Fund Trust 13G/A 22.8% 3y
VANGUARD GROUP INC SCS Steelcase, Inc. 13G/A 10.16% 3y
VANGUARD GROUP INC AMWD American Woodmark Corp 13G/A 10.11% 3y
Forbion Growth Opportunities Fund I Cooperatief U.A. ENGN enGene Therapeutics Inc. 13D 31.9% 3y
EVENTIDE ASSET MANAGEMENT, LLC XMTR Xometry, Inc. 13G 12.65% 3y
ArrowMark Colorado Holdings LLC SONX Sonendo, Inc. 13G/A 3.93% 3y
STATE STREET CORP NJR New Jersey Resources Corp 13G/A 5.3% 3y
T. Rowe Price Investment Management, Inc. NKTX Nkarta, Inc. 13G/A 0.8% 3y
NORTHERN TRUST CORP KLG WK Kellogg Co 13G 16.3% 3y
Bank of New York Mellon Corp AAXJ iShares Trust 13G/A 10.26% 3y
Capital Research Global Investors NCLH Norwegian Cruise Line Holdings Ltd. 13G 13.4% 3y
Bank of New York Mellon Corp ACGO Hartford Funds Exchange-Traded Trust 13G/A 13.27% 3y
Altamont Pharmaceutical Holdings, LLC GRTXD Galera Therapeutics, Inc. 13G 12.02% 3y
Alger Associates, Inc. 13-3017981 MASS 908 Devices Inc. 13G/A 3.8% 3y
PRICE T ROWE ASSOCIATES INC /MD/ BFAM Bright Horizons Family Solutions Inc. 13G/A 10.5% 3y
VANGUARD GROUP INC HA Hawaiian Holdings, Inc. 13G/A 5.18% 3y
VANGUARD GROUP INC INSM INSMED Inc 13G/A 10.07% 3y
Forbion Capital Fund III Cooperatief U.A. ENGN enGene Therapeutics Inc. 13G 14.2% 3y
GLAZER CAPITAL, LLC TRIS Tristar Acquisition I Corp. 13G/A 2.31% 3y
Invesco Ltd. DBE Invesco DB Energy Fund 13G/A 14.9% 3y
BIOS FUND I, LP RNTX Rein Therapeutics, Inc. 13G 9.99% 3y
Foundations Investment Advisors, LLC AAPR Innovator ETFs Trust 13G/A 36.8% 3y
BAKER BROS. ADVISORS LP CERS Cerus Corp 13G/A 10.5% 3y
VANGUARD GROUP INC ZIP Ziprecruiter, Inc. 13G/A 10.81% 3y
Alger Associates, Inc. 13-3017981 ALAI Alger ETF Trust 13G/A 50.1% 3y
VANGUARD GROUP INC VLTO Veralto Corp 13G 10.08% 3y
Capital World Investors FE Firstenergy Corp 13G 10.9% 3y
GLAZER CAPITAL, LLC WELNF Integrated Wellness Acquisition Corp 13G/A 0.01% 3y
Krishna Duvvuri WINT Windtree Therapeutics Inc 13G 6.35% 3y
Scott D. Kaufman PROP Prairie Operating Co. 13G 7.8% 3y
Antonis Palikrousis ATLX Atlas Lithium Corp 13G/A 10.35% 3y
Antonis Palikrousis ATLX Atlas Lithium Corp 13G 9.8% 3y
Gregory Boyd Penner VIEW View, Inc. Class A Common Stock 13G/A 18.8% 3y
Magnetar Financial LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13G/A 9.8% 3y